PHARMACOLOGY • CNS PHARMACOLOGY

General Anesthetics & Sedatives — General anesthetics and sedatives (overview)

Understanding the pharmacology of agents that reversibly depress consciousness, enabling modern surgery and procedural care.

Historical Context & Motivation

For millennia, surgical procedures were synonymous with unbearable pain. Ancient civilizations employed crude botanical concoctions — opium, mandrake root, and alcohol — to dull sensation, yet these preparations were unreliable, dangerous, and often insufficient. The quest for a safe, reproducible means of rendering a patient unconscious during surgery constitutes one of the most pivotal chapters in the history of medicine. The discovery and refinement of general anesthetics transformed surgery from a desperate, last-resort act into a controlled medical discipline, while the parallel development of sedatives expanded our ability to manage anxiety, agitation, and procedural discomfort across a wide spectrum of clinical contexts.

1842
Crawford Long's Ether Anesthesia
Crawford Long used diethyl ether to anesthetize a patient for surgical removal of a neck tumor, though he did not publish his findings until 1849. His work marked the earliest documented use of an inhalational anesthetic for surgery.
1846
The 'Ether Dome' Demonstration
William T.G. Morton publicly demonstrated ether anesthesia at Massachusetts General Hospital. This landmark event—often called 'Ether Day'—catalyzed the worldwide adoption of inhalational anesthesia and marked the birth of modern anesthesiology.
1934
Thiopental Introduced
The barbiturate thiopental was first used as an intravenous induction agent, ushering in the era of intravenous anesthesia. Its rapid onset made it the prototype for subsequent IV anesthetics and fundamentally changed induction practices.
1956
Halothane Enters Clinical Use
Halothane became the first non-flammable halogenated volatile anesthetic to achieve widespread use, replacing the explosive agents ether and cyclopropane. Its introduction spurred the development of the modern fluorinated anesthetics still in use today.
1989
Propofol Approved
Propofol received FDA approval and rapidly became the most widely used intravenous anesthetic for both induction and maintenance. Its favorable pharmacokinetic profile—rapid onset, short duration, and smooth recovery—set a new standard for ambulatory and procedural anesthesia.

Despite more than a century of clinical use, the precise molecular mechanisms by which general anesthetics produce unconsciousness remain an area of active investigation. The central question driving this field is deceptively simple: how can structurally diverse agents—ranging from noble gases like xenon to complex phenolic molecules like propofol—all converge on the same clinical endpoint of reversible unconsciousness? Understanding the pharmacology of these agents is essential for any healthcare professional involved in procedural care, critical care, or perioperative medicine.

Core Principles & Definitions

General anesthesia is a pharmacologically induced, reversible state comprising four cardinal features: unconsciousness (hypnosis), analgesia (freedom from pain), amnesia (no recall of events), and immobility (absence of movement in response to noxious stimuli). The term sedation refers to a continuum of CNS depression ranging from minimal anxiolysis to deep sedation approaching general anesthesia. Sedatives reduce anxiety and promote calm without necessarily abolishing consciousness, though dose escalation can blur the boundary between sedation and anesthesia.

1

Inhalational Anesthetics

Volatile liquids (sevoflurane, isoflurane, desflurane) and gases (nitrous oxide, xenon) administered via the lungs. Potency is quantified by minimum alveolar concentration (MAC). They primarily enhance GABAA receptor activity and inhibit NMDA receptors.
2

Intravenous Anesthetics

Agents such as propofol, etomidate, ketamine, and barbiturates that are injected directly into the bloodstream. They are used for rapid induction and, in some cases, total intravenous anesthesia (TIVA). Each agent has distinct receptor targets and hemodynamic profiles.
3

Sedative–Hypnotics

Benzodiazepines (midazolam, diazepam), barbiturates, and non-benzodiazepine hypnotics (zolpidem) that produce dose-dependent sedation. Benzodiazepines allosterically modulate GABAA receptors at a site distinct from barbiturates.
4

Sedation Continuum

The ASA defines four levels: minimal sedation (anxiolysis), moderate sedation ('conscious sedation'), deep sedation, and general anesthesia. Each level reflects a progressively greater depression of consciousness, airway reflexes, and cardiovascular function.
5

MAC — The Potency Standard

MAC is the minimum alveolar concentration of an inhalational agent at 1 atm that prevents movement in 50% of patients in response to a surgical incision. A lower MAC indicates greater potency. MAC is additive for combinations of inhalational agents.
KEY TAKEAWAY
Think of general anesthesia as a multi-layered dimmer switch for the brain, not a simple on/off switch. Each component — unconsciousness, analgesia, amnesia, and immobility — is controlled by different circuits and may require different pharmacological agents. A balanced anesthetic technique is like using several dimmer controls simultaneously to achieve the perfect lighting: if you rely on a single knob, you might need to turn it so far that you cause unwanted side effects, just as cranking one anesthetic to high doses can produce excessive cardiovascular depression.

Visual Explanation — The Sedation–Anesthesia Continuum

The diagram above illustrates the four-level sedation–anesthesia continuum defined by the American Society of Anesthesiologists. Note how responsiveness, airway protection, and cardiovascular stability degrade progressively as depth increases from left (minimal sedation, green) to right (general anesthesia, red). Typical agents are shown at each level.

An essential clinical insight is that sedation and general anesthesia exist along a continuum rather than as discrete, clearly demarcated states. A patient receiving moderate sedation can rapidly transition to deep sedation or even general anesthesia if additional doses are administered or if pharmacokinetic variability leads to higher-than-expected plasma concentrations. For this reason, any clinician administering sedation must be prepared to rescue a patient from a level deeper than intended — a principle that has profound implications for monitoring, equipment, and personnel requirements.

Mechanisms of Action — Molecular Targets of General Anesthetics

The earliest mechanistic hypothesis for anesthesia was the Meyer–Overton correlation (circa 1899–1901), which demonstrated a striking linear relationship between the lipid solubility of an anesthetic agent and its potency. This observation led to the lipid theory — the idea that anesthetics dissolve into neuronal membrane lipids and disrupt function in a non-specific manner. While the Meyer–Overton correlation remains a useful teaching tool, modern evidence strongly favors protein-based theories in which anesthetics interact with specific receptor proteins, particularly ligand-gated ion channels.

MEYER–OVERTON CORRELATION
MAC × λ(oil/gas) ≈ constant
Where MAC = minimum alveolar concentration (atm), and λ(oil/gas) = the oil:gas partition coefficient. The near-constancy of this product across structurally diverse agents suggests that potency correlates with lipophilicity. Agents with high oil solubility (high λ) achieve anesthesia at low concentrations (low MAC).

Key Molecular Targets

Modern anesthetics exert their effects through several well-characterized ion channel targets. The GABAA receptor — a pentameric chloride channel — is the principal inhibitory target for most IV and volatile anesthetics. Enhancement of GABAergic inhibition hyperpolarizes postsynaptic neurons, reducing excitability throughout the CNS. Propofol, etomidate, and barbiturates all potentiate GABAA receptor currents, though at different binding sites on the receptor. In contrast, ketamine is a non-competitive antagonist of the NMDA receptor — a glutamate-gated cation channel critical to excitatory neurotransmission. By blocking the NMDA receptor's ion channel pore, ketamine reduces excitatory drive and produces a unique 'dissociative' state.

Additional targets include two-pore-domain potassium channels (K₂ₚ), which are activated by volatile anesthetics, leading to membrane hyperpolarization. Glycine receptors — inhibitory chloride channels concentrated in the spinal cord — are particularly relevant to the immobility component of anesthesia and may explain why supraspinal mechanisms alone do not account for MAC. The diversity of targets underscores why a single 'unitary theory' of anesthetic action has proven elusive, and why the clinical effects of different agents can vary substantially despite the shared endpoint of unconsciousness.

This diagram maps the four principal molecular targets of general anesthetics. The GABAA receptor (violet, top-left) is the dominant target for most IV and volatile agents. The NMDA receptor (pink, top-right) is blocked by ketamine and nitrous oxide. K₂ₚ potassium channels (cyan, bottom-left) and glycine receptors (amber, bottom-right) contribute to hyperpolarization and spinal immobility, respectively.
🔬 Clinical Correlation
Because ketamine acts primarily at NMDA receptors rather than GABAA receptors, it produces a dissociative anesthesia — a trance-like state with preserved airway reflexes and sympathomimetic cardiovascular effects. This unique pharmacodynamic profile makes ketamine invaluable in settings where hemodynamic instability or limited airway management resources preclude the use of traditional IV anesthetics like propofol.

Detailed Classification of Agents

General anesthetics and sedatives can be organized into several pharmacological classes based on their route of administration, chemical structure, and receptor selectivity. The table below provides a comparative overview of the most clinically relevant agents, highlighting their onset, duration, primary molecular targets, and distinguishing clinical features. Understanding these distinctions is critical for selecting the appropriate agent for a given clinical scenario — for example, choosing a short-acting agent for ambulatory procedures versus a hemodynamically stable agent for cardiac surgery.

Comparative pharmacology of major general anesthetics and sedatives.
AgentClassPrimary TargetOnsetKey Clinical Features
SevofluraneVolatile inhalationalGABAA, K₂ₚ, Glycine1–3 minNon-pungent; excellent for inhalational induction in children; mild cardiac depression
DesfluraneVolatile inhalationalGABAA, K₂ₚ, Glycine1–2 minLowest blood:gas solubility → fastest recovery; pungent, causes airway irritation
Nitrous oxideGaseous inhalationalNMDA antagonism2–5 minAnalgesic; low potency (MAC = 104%); diffusion hypoxia risk on discontinuation
PropofolIV — AlkylphenolGABAA potentiation15–45 secSmooth induction/emergence; antiemetic; ↓ BP via vasodilation; lipid emulsion vehicle
EtomidateIV — ImidazoleGABAA (β₂/β₃ subunits)15–45 secHemodynamically stable; adrenocortical suppression; myoclonus on induction
KetamineIV — Phencyclidine derivativeNMDA antagonism30–60 sec IVDissociative anesthesia; sympathomimetic ↑ HR, ↑ BP; bronchodilation; emergence delirium
MidazolamIV/oral — BenzodiazepineGABAA (BZD site)1–3 min IVAnxiolysis, amnesia, sedation; reversible with flumazenil; minimal hemodynamic effect
DexmedetomidineIV — α₂-agonistα₂-adrenergic (locus coeruleus)5–10 minCooperative sedation (patient arousable); no respiratory depression; bradycardia risk
Blood:Gas Partition Coefficient (Solubility) of Inhalational Agents
Desflurane (0.42)
N₂O (0.47)
Sevoflurane (0.65)
Isoflurane (1.46)
Halothane (2.4)
Low solubility → Fast onset/recoveryHigh solubility → Slow onset/recovery

The blood:gas partition coefficient is the key determinant of speed of induction and recovery for inhalational agents. A lower coefficient means less anesthetic dissolves in the blood, allowing the alveolar (and therefore brain) partial pressure to equilibrate quickly with the inspired concentration. Desflurane and nitrous oxide, with the lowest coefficients, produce the fastest onset and offset. Conversely, halothane's high solubility results in a slower wash-in and longer recovery. This pharmacokinetic principle is why desflurane and sevoflurane have largely supplanted older agents in modern practice.

Worked Example — Calculating Combined MAC Values

In clinical practice, anesthesia providers commonly use combinations of inhalational agents (e.g., nitrous oxide combined with a volatile agent) to achieve adequate surgical anesthesia while minimizing the side effects of any single agent. Because MAC values are additive, we can calculate the fractional contributions of each agent to determine whether the total anesthetic depth is sufficient.

MAC ADDITIVITY
Total MAC = (C₁ / MAC₁) + (C₂ / MAC₂)
Where C₁ and C₂ are the end-tidal concentrations of agents 1 and 2, and MAC₁ and MAC₂ are their respective individual MAC values. A total MAC of 1.0 corresponds to surgical anesthesia adequate for 50% of patients; a target of 1.2–1.3 MAC is often used clinically.
Combined MAC of Sevoflurane + Nitrous Oxide
1
Step 1 — Identify Known MAC ValuesMAC of sevoflurane = 2.0% (in 100% O₂ at 1 atm in a healthy 40-year-old adult). MAC of nitrous oxide = 104% (this means N₂O cannot achieve 1.0 MAC at atmospheric pressure alone). These values serve as our denominators in the additivity equation.
2
Step 2 — Determine Delivered ConcentrationsA patient is receiving 60% nitrous oxide and 1.0% sevoflurane as measured by end-tidal gas analysis. These concentrations represent C₁ and C₂ in our equation.
Csevo = 1.0%, CN₂O = 60%
3
Step 3 — Calculate Fractional MAC ContributionsFractional MAC from sevoflurane = 1.0% / 2.0% = 0.50 MAC. Fractional MAC from nitrous oxide = 60% / 104% ≈ 0.58 MAC. Each agent contributes a fraction of its own MAC value, and these fractions sum linearly.
Sevo: 0.50 MAC; N₂O: 0.58 MAC
4
Step 4 — Sum for Total MACTotal MAC = 0.50 + 0.58 = 1.08 MAC. This means the anesthetic depth is equivalent to 1.08 times the MAC of a single agent — slightly above the threshold at which 50% of patients would not move in response to a surgical stimulus. For most surgical procedures, the anesthesiologist would consider this adequate for lighter surgical stimulation but might increase to approximately 1.2–1.3 MAC for more stimulating procedures.
Total MAC = 1.08
⚕️ Clinical Note
MAC varies with patient factors. MAC decreases by approximately 6% per decade of age after age 40, is reduced by hypothermia, acute alcohol intoxication, and concurrent opioid administration, and is increased by chronic alcohol or amphetamine use, hyperthermia, and young age (infants have the highest MAC). Always adjust target MAC for the individual patient.

Strengths & Limitations — Inhalational vs. Intravenous Techniques

Two dominant strategies exist for delivering general anesthesia: inhalational anesthesia using volatile agents and total intravenous anesthesia (TIVA) using agents such as propofol and remifentanil. Each approach has distinct pharmacokinetic advantages, disadvantages, and clinical niches. The choice between them often depends on patient comorbidities, the type of surgery, environmental considerations, and institutional resources.

Comparison of inhalational versus total intravenous anesthetic techniques.
ParameterInhalational (Volatile)TIVA (IV — Propofol-based)
Depth monitoringEnd-tidal concentration provides real-time surrogate of brain partial pressure (MAC equivalent)No direct measure of brain concentration; relies on pharmacokinetic models and processed EEG (BIS)
Induction speedSlower (minutes); acceptable for mask induction in pediatricsRapid (15–45 sec); preferred for adults
Recovery profileContext-sensitive; desflurane/sevoflurane allow rapid emergencePropofol: generally rapid but context-sensitive half-time increases with prolonged infusion
PONV riskHigher incidence (volatiles are emetogenic)Lower; propofol has intrinsic antiemetic properties
Malignant hyperthermiaAll volatile agents are triggering agentsTIVA is the safe alternative for MH-susceptible patients
Environmental impactGreenhouse gas emissions (desflurane >> sevoflurane); waste gas scavenging requiredNo atmospheric release; single-use plastics are the primary environmental concern
KEY TAKEAWAY
No single technique is universally superior. Think of the choice between inhalational and IV anesthesia like choosing between two navigation systems — both get you to the destination (unconsciousness), but one provides continuous GPS tracking (end-tidal monitoring for volatiles) while the other uses estimated-time-of-arrival algorithms (pharmacokinetic modeling for TIVA). In high-risk patients, such as those susceptible to malignant hyperthermia, TIVA is not merely preferred but mandatory, while a straightforward pediatric mask induction leverages the unique advantage of inhalational agents.

Connections to Advanced Anesthesiology

The foundational concepts presented in this overview serve as the gateway to more advanced topics in anesthesia pharmacology. Understanding how general anesthetics interact with their targets at the molecular level prepares you for deeper study of pharmacokinetic modeling, receptor pharmacology, and the neuroscience of consciousness. The table below maps the core concepts from this lesson to their advanced extensions.

Pathway from introductory to advanced anesthesia pharmacology topics.
Core Concept (This Lesson)Advanced Extension
MAC and the Meyer–Overton correlationExceptions to Meyer–Overton (non-immobilizers, cut-off effect); agent-specific MAC modifications (MAC-BAR, MAC-awake)
GABAA potentiationSubunit-specific binding sites (α₁ for sedation vs. α₅ for amnesia); allosteric modulation vs. direct activation
Sedation continuumEEG-based depth-of-anesthesia monitoring (BIS, entropy); neural correlates of consciousness under anesthesia
Blood:gas solubilityMulti-compartment pharmacokinetic models; context-sensitive half-times; effect-site equilibration (ke0)
Ketamine's NMDA antagonismSub-anesthetic ketamine for treatment-resistant depression; opioid-sparing multimodal analgesia; S-ketamine (esketamine) pharmacology

One particularly active area of research involves the neural mechanisms of anesthetic-induced unconsciousness. Current evidence suggests that general anesthetics do not simply 'turn off' the brain globally; rather, they disrupt the coordinated information integration across cortical networks — a concept closely aligned with the integrated information theory (IIT) of consciousness. Functional imaging studies show that volatile anesthetics preferentially suppress thalamocortical connectivity, fragmenting the brain's ability to process information as a unified whole. These insights are not merely academic — they are driving the development of next-generation depth-of-anesthesia monitors that aim to detect awareness under anesthesia with far greater sensitivity than existing tools.

Practice Problems

PROBLEM 1CONCEPTUAL
A patient is classified as being under 'moderate sedation' according to the ASA sedation continuum. Describe the expected state of the patient's responsiveness, airway reflexes, and spontaneous ventilation at this level. Why must a clinician providing moderate sedation be prepared to manage a deeper level of CNS depression?
PROBLEM 2BASIC CALCULATION
The MAC of isoflurane is 1.15% in a 40-year-old healthy adult. If a patient is receiving 0.8% isoflurane, what fraction of MAC is being delivered? Would this be expected to prevent movement to a surgical stimulus in the majority of patients?
PROBLEM 3INTERMEDIATE
An anesthesiologist administers a combination of 50% nitrous oxide (MAC = 104%) and desflurane (MAC = 6.0%). If the target total MAC is 1.2, what end-tidal desflurane concentration is needed to supplement the nitrous oxide?
PROBLEM 4APPLIED
A trauma patient presents to the emergency department in hemorrhagic shock (hypotensive, tachycardic) requiring emergent surgical fixation. The anesthesiologist must choose between propofol and ketamine for induction of general anesthesia. Based on their pharmacodynamic profiles, which agent is more appropriate, and why? What specific molecular mechanism underlies the hemodynamic advantage of your chosen agent?
PROBLEM 5CRITICAL THINKING
The Meyer–Overton correlation predicts that anesthetic potency should correlate linearly with lipid solubility. However, certain highly lipophilic compounds (e.g., some long-chain alcohols and perfluoroalkanes) fail to produce anesthesia despite exceeding predicted potency based on their oil:gas partition coefficients. These are termed 'non-immobilizers.' What does the existence of non-immobilizers imply about the mechanism of general anesthesia, and how does this observation support modern protein-based theories over the classical lipid theory?

Lesson Summary

General anesthetics and sedatives are pharmacological agents that produce a reversible depression of CNS function along a continuum that spans from minimal sedation (anxiolysis) to general anesthesia. The four pillars of general anesthesia — unconsciousness, analgesia, amnesia, and immobility — are mediated by distinct neural circuits and receptor systems. Inhalational agents (sevoflurane, desflurane, isoflurane, nitrous oxide) are quantified by MAC, an additive measure of potency inversely related to the oil:gas partition coefficient. Intravenous agents (propofol, etomidate, ketamine) provide rapid induction and are the foundation of TIVA. Speed of onset and recovery for inhalational agents is governed by the blood:gas partition coefficient — lower solubility enables faster equilibration.

At the molecular level, most agents enhance inhibitory neurotransmission via GABAA receptor potentiation or reduce excitatory neurotransmission via NMDA receptor blockade, with additional contributions from two-pore potassium channels and glycine receptors. The existence of non-immobilizers has shifted the field from the classical Meyer–Overton lipid theory toward modern protein-based models of anesthetic action. Clinically, the choice between inhalational and IV techniques depends on patient-specific factors, with agents like ketamine offering unique hemodynamic and respiratory advantages in select populations.

Varsity Tutors • Pharmacology • General Anesthetics & Sedatives — General anesthetics and sedatives (overview)